Czy antagoniści receptorów angiotensynowych AT1 (sartany) mogą zwiększać ryzyko wystąpienia choroby nowotworowej? Komentarz kardiologa i hipertensjologa Commentary

Article Sidebar

PDF (Język Polski)


Published: Mar 30, 2012

Main Article Content

Krzysztof J. Filipiak
I Katedra i Klinika Kardiologii Warszawskiego Uniwersytetu Medycznego

Abstract

None

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Article Details

How to Cite
1.
Filipiak KJ. Czy antagoniści receptorów angiotensynowych AT1 (sartany) mogą zwiększać ryzyko wystąpienia choroby nowotworowej? Komentarz kardiologa i hipertensjologa. OncoReview [Internet]. 2012Mar.30 [cited 2024Jul.23];2(1(5):63-4. Available from: https://journalsmededu.pl/index.php/OncoReview/article/view/297
Issue
Vol 2 No 1(5) (2012)
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)